• No results found

[PDF] Top 20 A REVIEW OF BREAST CANCER AND HORMONAL THERAPY

Has 10000 "A REVIEW OF BREAST CANCER AND HORMONAL THERAPY" found on our website. Below are the top 20 most common "A REVIEW OF BREAST CANCER AND HORMONAL THERAPY".

A REVIEW OF BREAST CANCER AND HORMONAL THERAPY

A REVIEW OF BREAST CANCER AND HORMONAL THERAPY

... of Breast Cancer in India: Age incidence rates in India suggest that the disease peaks at a younger age ...patterns. Breast cancer rates tend to be higher in women of higher education and in ... See full document

9

Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials

Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials

... endocrine therapy for patients with hormonosensitive breast cancer are well ...endocrine therapy is much more recent and less reported in the ...endocrine therapy seems to be ... See full document

12

Altered radiation responses of breast cancer cells resistant to hormonal therapy

Altered radiation responses of breast cancer cells resistant to hormonal therapy

... hormone therapy and radiation is widely used in clinical ...render cancer cells less responsive to radiotherapy by providing a protective effect against ...and hormonal therapy administration ... See full document

17

THE WORLD OF BREAST CANCER - A REVIEW

THE WORLD OF BREAST CANCER - A REVIEW

... „Breast cancer‟ is most ...the breast cancer. Though there are many different types of cancer treatments like chemotherapy (chemotherapy medicines prevent cancer cells from ... See full document

10

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

... Basal-like breast cancer is an aggressive tumor subtype with a poor response to conventional ...of Breast Cancer Stem Cells ...basal-like cancer through Polo-like kinase1 (Plk1) down- ... See full document

16

Review on Diagnosis and Treatment of Breast Cancer

Review on Diagnosis and Treatment of Breast Cancer

... Breast cancer is the second leading disease in women ...by cancer. Early prognosis of breast cancer is more ...of breast cancer depends mainly on menarche at an early age ... See full document

8

DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation

DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation

... target gene [32] suggesting that receptor levels alone could not accurately predict Notch signalling (Figure 1A). LTED cells have impaired ERα signalling as a consequence of estradiol starvation, thus suggesting that ... See full document

13

Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review

Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review

... the review was useful, there were several limitations, which are addressed by the current ...targeted review of modifiable psychosocial pre- dictors would provide further guidance for the development of an ... See full document

18

Factors influencing oncologists’ prescribing hormonal therapy in women with breast cancer: a qualitative study in Córdoba, Argentina

Factors influencing oncologists’ prescribing hormonal therapy in women with breast cancer: a qualitative study in Córdoba, Argentina

... The fragmented nature of the Argentinian health sys- tem has often been identified as a cause of main health inequalities, between and within provinces, including cancer diagnosis and treatment [47] as well as ... See full document

13

Expectations of breast-conserving therapy: a qualitative study

Expectations of breast-conserving therapy: a qualitative study

... Institutional Review Board before initiation of the ...early-stage breast cancer, were plan- ning to have BCT or had undergone BCT within 6–12 months, spoke English, were able to participate in an ... See full document

8

Reproductive and hormonal risk factors of breast cancer: a historical perspective

Reproductive and hormonal risk factors of breast cancer: a historical perspective

... of breast cancer etiology has puzzled scientists for more than 300 ...brief review, we emphasize the importance of reproductive and hormonal factors in relation to the risk of breast ... See full document

8

Breast cancer screening practices for women aged 35 to 49 and 70 and older

Breast cancer screening practices for women aged 35 to 49 and 70 and older

... For women aged 35 to 49 years, more than 80% of physicians reported using practices deemed adequate, except for instruction in BSE and referral for genetic counseling (60% and 54%). For women 70 years of age and older ... See full document

7

Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer

Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer

... Prostate cancer is one of the leading causes of cancer deaths among men in the United ...and hormonal therapy. Hormonal therapy has become a mainstay of palliative treatment for ... See full document

9

Sex Steroids and Breast Cancer: An Overview

Sex Steroids and Breast Cancer: An Overview

... of hormonal therapy) as it has been shown to offer more benefits than 5 years of tamoxifen ...for breast cancer recurrence and survival clearly support their use in all postmenopausal women ... See full document

6

Clinicopathological Characteristics of Male Breast Cancer

Clinicopathological Characteristics of Male Breast Cancer

... hormone therapy), disease-free survival, and overall survival were obtained by reviewing medical ...on Cancer (AJCC) ...for hormonal receptor ... See full document

9

Original Article Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma

Original Article Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma

... by hormonal therapy, chemotherapy, or radiation therapy was made according to widely used guidelines (hormonal therapy: 71/82 ...radiation therapy 23/82 ...on Cancer ... See full document

15

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH

Click here to download PDF version of the article !

... require therapy, as the effusions are small and ...lymphomas, breast cancer, small cell lung cancer, or ovarian cancer may respond to systemic chemotherapy or hormonal ... See full document

5

Hormone therapy for breast cancer

Hormone therapy for breast cancer

... the breast cancer cells resulting in deformation of the estrogen receptors and reduce estrogen ...metastatic breast cancer in postmenopausal ...line therapy in case the postmenopausal ... See full document

7

Endocrine therapy for breast cancer: a model of hormonal manipulation

Endocrine therapy for breast cancer: a model of hormonal manipulation

... Clinical benefit is a key principle in endo- crine therapy decision-making in advanced ER? disease. Patients will be commenced on the best agent first. After 6 months of treatment, patients who have stable disease ... See full document

16

The Risk of Relationship between Hormonal Replacement Therapy and Cancer

The Risk of Relationship between Hormonal Replacement Therapy and Cancer

... lack hormonal activity, hormone replacement therapy has been developed (TRH), which is widely used around the world, often without criteria ...identify hormonal therapies used postmenopausal and ... See full document

8

Show all 10000 documents...